News Maxor’s Response to the Coronavirus Mar 13, 2020 Clinical News, COVID-19, Maxor Pharmacy Management, Maxor Specialty, Maxor340B, MaxorPlus This memo details Maxor’s perspective on the current COVID-19 situation and contingency planning across Maxor’s various business lines, including PBM, retail/hospital pharmacy, and specialty pharmacy. READ MORE Related News Topic #5: Navigating Requirements and Earning Accreditations. Blog, Maxor, Maxor340B Laying the Foundation for an Innovative 2024 in Pharmacy Benefit Management Blog, Clinical News, MaxorPlus Topics #3 and #4 : Staff shortages and collaborative practice agreements. Blog, Maxor, Maxor340B See more news. Categories Blog Clinical News COVID-19 Cystic Fibrosis Industry News Maxor Maxor Pharmacy Management Maxor Specialty Maxor340B MaxorPlus Press Releases Uncategorized
Laying the Foundation for an Innovative 2024 in Pharmacy Benefit Management Blog, Clinical News, MaxorPlus